))
The Benefits of Early Launch Planning
Manage episode 417334664 series 3046075
Content provided by Vynamic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vynamic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it’s become essential to start commercialization planning earlier to ensure a successful launch and hit revenue targets. In this deep dive episode, Jen is joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, as well as Managing Director of PROPENSITY4, Chris Savage, to discuss why early planning is so critical and how leaders can incorporate some of these changes into their organizations.
To learn more about Vynamic’s work in Product Launch, visit Vynamic’s Product Launch page. To read more on navigating alliance product launches, see Vynamic’s latest insight here.
PROPENSITY4, part of Inizio Engage, is transforming pharmaceutical commercialization through seamless integration of data, expertise and cutting-edge analytics. See more about what PROPENSITY4 can do for your team at Data and Integrated Insights | Inizio Engage.
Podcast Tags: healthcare, life sciences, product launch, healthcare news, life sciences trends, product launch trends
Source Links:
- Product launch challenges and how to overcome them
- Drug launches reflect overall company performance
- TO SPEND OR NOT TO SPEND: Investing For Launch Success As An Emerging Company
- Revenue of the worldwide pharmaceutical market from 2001 to 2023
- Prices for new US drugs rose 35% in 2023, more than the previous year
- Next in pharma 2024: Reinventing for returns
- The Unbearable Cost of Drug Development
- Understanding the Factors that Impact the Pre-Launch Phase and New Product Launch Excellence in the Pharmaceutical Industry
- FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers
Panel – Jen Burke, Ashley Stanley, Chris Savage, Brian Stamm
Research & Production – Adrea Cope & Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
182 episodes
Share
